Mortality among tuberculosis patients under DOTS programme: a historical cohort study by Yeshiwork Beyene, Berhanu Geresu, Assefa Mulu

Get full text

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders by Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, Emmanuel S. Onaivi

Get full text

Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation by Berhanu Geresu Kibret, Ana Canseco-Alba, Emmanuel S. Onaivi, Ephrem Engidawork

Get full text

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders by Hiroki Ishiguro, Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, Emmanuel S. Onaivi

Get full text

Involvement of CB2 Receptors in the Neurobehavioral Effects of <i>Catha Edulis</i> (Vahl) Endl. (Khat) in Mice by Berhanu Geresu, Ana Canseco-Alba, Branden Sanabria, Zhicheng Lin, Qing-Rong Liu, Emmanuel S. Onaivi, Ephrem Engidawork

Get full text

Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors by Aaliyah Roberts, Mahli Christian, Lizbeth Nivar Dilone, Natania Nelson, Mark Joseph Endrino, Adam Kneebone, Shymaa Embaby, Justin Fernandez, Qing-Rong Liu, Emmanuel S. Onaivi, Berhanu Geresu Kibret

Get full text